Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
OLMA
Stock Latest News
Ratings
Olema Maintained at Buy as Differentiated Pipeline and Robust Trial Strategy Support Unchanged $24 Price Target
9d ago
OLMA
Premium
Company Announcements
Olema Investors Back Board, Pay and Auditor Decisions
18d ago
8K
OLMA
Premium
Ratings
Olema Pharmaceuticals: Clinical Momentum and Strategic Flexibility Support Buy Rating and Maintain $38 Price Target
1M ago
OLMA
Premium
Ratings
Olema Pharmaceuticals: Buy Rating Reiterated as Pipeline Progress Supports Attractive Risk/Reward with Unchanged $62 Price Target
1M ago
OLMA
Premium
The Fly
Olema Oncology announces collaboration, supply agreement with Bayer
2M ago
OLMA
Premium
Company Announcements
Olema, Bayer launch OP-3136 prostate cancer collaboration
2M ago
8K
OLMA
Premium
Company Announcements
Olema Highlights Encouraging OP-3136 Phase 1 Oncology Results
2M ago
8K
OLMA
Premium
The Fly
Citi opens ‘upside 90-day catalyst watch’ on Olema Oncology
2M ago
OLMA
Premium
Ratings
Olema Pharmaceuticals: Citi’s Anupam Rama Reiterates Buy on Underappreciated Palazestrant Upside and Long-Term Pipeline Catalysts
2M ago
OLMA
Premium
The Fly
Olema Oncology price target lowered to $35 from $38 at Guggenheim
2M ago
PFE
OLMA
Premium
Ratings
Olema Pharmaceuticals: Differentiated KAT6i and Palazestrant Pipeline Catalysts Underpin Buy Rating
2M ago
OLMA
Premium
The Fly
Olema Oncology reports Q1 EPS (52c), consensus (54c)
2M ago
OLMA
Premium
Company Announcements
Olema Pharmaceuticals Signs New Headquarters Lease at Oyster Point
2M ago
8K
OLMA
Premium
Company Announcements
Olema Pharmaceuticals Adds Veteran Director to Support Growth
2M ago
8K
OLMA
Premium
The Fly
Olema Oncology to present initial clinical data for OP-3136 at ASCO
3M ago
OLMA
Premium
The Fly
Olema Oncology announces preclinical data for Palazestrant
3M ago
OLMA
Premium
The Fly
Olema Oncology initiated with a Peer Perform at Wolfe Research
4M ago
OLMA
Premium
The Fly
Olema Oncology assumed with a Buy at Jefferies
4M ago
OLMA
Premium
The Fly
Olema Oncology price target raised to $58 from $55 at JPMorgan
4M ago
OLMA
Premium
The Fly
Olema Oncology price target lowered to $27 from $38 at Goldman Sachs
4M ago
OLMA
Premium
The Fly
Olema Oncology price target lowered to $38 from $40 at Guggenheim
4M ago
AZN
CHRO
Premium
The Fly
Olema Oncology price target raised to $62 from $60 at Citi
4M ago
OLMA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
